The Latest Breaking News from Disease

The man who killed four people in the New York City skyscraper that is home to NFL headquarters carried a note blaming the league for the cognitive problems he developed as a high school football player

A groundbreaking Australian study is using DNA analysis to pinpoint a person's genetic risk of developing multiple sclerosis.

The league first publicly accepted there was a link between the sport and the incurable brain disease in 2016 – but still outright denied claims

CTE has been diagnosed in former professional football and hockey players

Learn about dementia, how it affects people, how it's diagnosed and what treatments are available.

The U.S. Food and Drug Administration approved on Monday Apellis Pharmaceuticals, Inc.’s (NASDAQ:APLS) Empaveli (pegcetacoplan) as the first treatment for C3 glomerulopathy (C3G) or primary immune complex membranoproliferative glomerulonephritis (IC-MPGN) in patients 12 years of age and older, to reduce proteinuria.

Shane Tamura, the suspected Midtown NYC shooter, referenced CTE a degenerative brain disease in a chilling note before the attack. The mention has raised fresh questions about mental health and accountability in violent crimes.

The first malaria treatment for babies and very young children of 2 months up to 5 years was approved for use by Swiss agency for therapeutic products, Swissmedic, in early July 2025. Until now, babies and very young children have been treated with medicines formulated for older children.

Detectives still trying to determine motive in attack that killed four in Manhattan on Monday

Experts call for urgent global action on hepatitis, alcohol, and obesity as new data shows that while preventable liver cancer cases are on the rise, the right mix of policy, prevention, and public awareness could save millions of lives.

There are currently estimated to be 982,000 people with some form of dementia, including Alzheimer's in the UK